Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy
暂无分享,去创建一个
S. Luoh | G. Hortobagyi | L. Vahdat | L. Provencher | T. Schmelter | S. Divers | T. Petrella | P. K. Morrow | Yao Wang | M. Giurescu